Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Strawberry drink shows promise for heart health in overweight adults

NCT ID NCT04094103

Disease control Sponsor: Carl Ade, M.S., Ph.D. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at whether drinking a strawberry beverage every day for four weeks could improve cholesterol, blood sugar, and other heart health markers in overweight or obese adults. Forty-eight participants with borderline-high cholesterol and normal to slightly elevated blood pressure were randomly assigned to receive either active strawberry powder, a placebo, or a mix. The goal was to see if strawberries could help reduce the risk of heart disease and diabetes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
strawberry powder
What this could lead to
If it works, this could point toward a simple dietary addition to help manage cholesterol and blood sugar in overweight individuals.
What could go wrong
This is a small, completed study with only 48 participants, so results may not apply to everyone. It tested a supplement, not whole strawberries, and benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

48 people

The number who actually took part.

Started

Oct 2019

Finished

Oct 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Overweight or obese by BMI (25.0-34.9kg/m2), * Borderline-high LDL-cholesterol (130-159mg/dL), * Normal or elevated blood pressure ((≤129mmHg/≤80mmHg) Exclusion Criteria: * known allergy or intolerance to strawberries * taking any medications for chronic diseases including anti-inflammatory, anti-hypertensive, lipid-lowering, glucose-controlling, or steroidal medications * taking any supplements that might affect outcomes of the study including anti-oxidant or fish-oil supplements * having anemia or any liver, thyroid, renal conditions * current smoker or user of tobacco products, or use within the past three months * consuming alcohol (\>1-2 drinks/day) on a regular basis * currently pregnant or lactating * having elevated blood pressure ≥130mmHg/≥80mmHg * presence of diagnosed diabetes mellitus, inflammatory disease, atherosclerotic disease, or other relevant chronic conditions * total cholesterol ≥240mg/dL * hemoglobin normal range values for males (between 13.0-17.5g/dL) and females (between 12.5-15.5g/dL)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome metabolic syndrome X Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metabolic syndrome Obesity

Contacts and locations

Locations

  • Lafene Health Center

    Manhattan, Kansas, 66502, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.